LONDON (Reuters) - Medicines cost-effectiveness watchdog NICE on Wednesday approved a new class of drugs called aromatase inhibitors for older women suffering from breast cancer.Today's announcement should finally put an end to the postcode lottery for aromatase inhibitors (AIs) such as anastrozole
read more »
Source:http://today.reuters.co.uk DiscussBury
Medinews is an online community dedicated for promoting and discussing latest medical news, research articles and blogs. You can also find regular updates on health news for discussion by health professionals.